Literature DB >> 25945716

Structures of prostaglandin F synthase from the protozoa Leishmania major and Trypanosoma cruzi with NADP.

Spencer O Moen1, James W Fairman1, Steve R Barnes1, Amy Sullivan1, Stephen Nakazawa-Hewitt1, Wesley C Van Voorhis1, Bart L Staker1, Donald D Lorimer1, Peter J Myler1, Thomas E Edwards1.   

Abstract

The crystal structures of prostaglandin F synthase (PGF) from both Leishmania major and Trypanosoma cruzi with and without their cofactor NADP have been determined to resolutions of 2.6 Å for T. cruzi PGF, 1.25 Å for T. cruzi PGF with NADP, 1.6 Å for L. major PGF and 1.8 Å for L. major PGF with NADP. These structures were determined by molecular replacement to a final R factor of less than 18.6% (Rfree of less than 22.9%). PGF in the infectious protozoa L. major and T. cruzi is a potential therapeutic target.

Entities:  

Keywords:  Chagas disease; SSGCID; infectious diseases; leishmaniasis; prostaglandin

Mesh:

Substances:

Year:  2015        PMID: 25945716      PMCID: PMC4427172          DOI: 10.1107/S2053230X15006883

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  16 in total

1.  Ligation-independent cloning of PCR products (LIC-PCR).

Authors:  C Aslanidis; P J de Jong
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7.

Authors:  Gerrit Langer; Serge X Cohen; Victor S Lamzin; Anastassis Perrakis
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Comparison of super-secondary structures in proteins.

Authors:  S T Rao; M G Rossmann
Journal:  J Mol Biol       Date:  1973-05-15       Impact factor: 5.469

Review 4.  The Seattle Structural Genomics Center for Infectious Disease (SSGCID).

Authors:  P J Myler; R Stacy; L Stewart; B L Staker; W C Van Voorhis; G Varani; G W Buchko
Journal:  Infect Disord Drug Targets       Date:  2009-11

5.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 7.  Cutaneous leishmaniasis treatment.

Authors:  Philippe Minodier; Philippe Parola
Journal:  Travel Med Infect Dis       Date:  2006-10-31       Impact factor: 6.211

8.  Gene Composer in a structural genomics environment.

Authors:  Don Lorimer; Amy Raymond; Mark Mixon; Alex Burgin; Bart Staker; Lance Stewart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-13

9.  Induction of resistance to azole drugs in Trypanosoma cruzi.

Authors:  F S Buckner; A J Wilson; T C White; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  3 in total

1.  Leishmania braziliensis prostaglandin F synthase impacts host infection.

Authors:  Eliza Vanessa Carneiro Alves-Ferreira; Tiago Rodrigues Ferreira; Pegine Walrad; Paul M Kaye; Angela Kaysel Cruz
Journal:  Parasit Vectors       Date:  2020-01-08       Impact factor: 3.876

2.  Transcriptome Analysis of Intracellular Amastigotes of Clinical Leishmania infantum Lines from Therapeutic Failure Patients after Infection of Human Macrophages.

Authors:  Raquel García-Hernández; Ana Perea-Martínez; José Ignacio Manzano; Laura C Terrón-Camero; Eduardo Andrés-León; Francisco Gamarro
Journal:  Microorganisms       Date:  2022-06-27

3.  A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism.

Authors:  Adam J Roberts; Joanne Dunne; Paul Scullion; Suzanne Norval; Alan H Fairlamb
Journal:  Biochem J       Date:  2018-08-30       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.